CLINICAL_TRIALS trial_result · 2017-12-22

Clinical Trial Update: Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes [Phase 4]

Phase 4 clinical trial investigating genetic influences on response to beta-blocker medications in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Maryland, Baltimore | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2017-12-22